Skip to main content
Other
MOLECULAR MALIGNANCY IN MELANOCYTIC LESIONS
(2013)
  • Hui Wang, HTG Molecular Diagnostics, INc. (Tucson, AZ, US) John Wayne Cancer Institute (Santa Monica, CA, US)
  • Christopher Roberts, HTG Molecular Diagnostics, INc. (Tucson, AZ, US) John Wayne Cancer Institute (Santa Monica, CA, US)
  • Krishna Maddula, HTG Molecular Diagnostics, INc. (Tucson, AZ, US) John Wayne Cancer Institute (Santa Monica, CA, US)
  • Zhenquiang Lu, HTG Molecular Diagnostics, INc. (Tucson, AZ, US) John Wayne Cancer Institute (Santa Monica, CA, US)
  • Justin Brown, HTG Molecular Diagnostics, INc. (Tucson, AZ, US) John Wayne Cancer Institute (Santa Monica, CA, US)
  • Tom Vasicek, HTG Molecular Diagnostics, INc. (Tucson, AZ, US) John Wayne Cancer Institute (Santa Monica, CA, US)
  • B.J. Kerns, HTG Molecular Diagnostics, INc. (Tucson, AZ, US) John Wayne Cancer Institute (Santa Monica, CA, US)
  • Bruce Seligmann, HTG Molecular Diagnostics, INc. (Tucson, AZ, US) John Wayne Cancer Institute (Santa Monica, CA, US)
  • Dave S.B. Hoon
Disciplines
Publication Date
June 24, 2013
Citation Information
Hui Wang, Christopher Roberts, Krishna Maddula, Zhenquiang Lu, et al.. "MOLECULAR MALIGNANCY IN MELANOCYTIC LESIONS" (2013)
Available at: http://works.bepress.com/dave-hoon/111/